Skip to main content

Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Wednesday, April 27, 2022
  • 9:00 AM – 9:10 AM
    Welcome and Introduction
  • 9:10 AM – 9:45 AM
    Should We Transplant Patients with Multiple Myeloma (MM)
  • 9:45 AM – 9:55 AM
    Live Q&A Panel
  • 9:55 AM – 10:10 AM
    Break
  • 10:10 AM – 10:45 AM
    Inpatient and Outpatient Treatment Algorithms for the Management of Acute Myeloid Lymphoma in Patients with Genetic Mutations
  • 10:55 AM – 11:10 AM
    Break
  • 11:10 AM – 12:10 PM
    Non-CME Innovation Theater
  • 12:10 PM – 12:25 PM
    Break
  • 12:25 PM – 1:00 PM
    Challenging Case Review – Breast Cancer Patients
  • 1:00 PM – 1:10 PM
    Live Q&A Panel
  • 1:10 PM – 1:25 PM
    Break
  • 2:10 PM – 2:25 PM
    Break
  • 2:25 PM – 3:00 PM
    Pain Management in Cancer Patients with Opioid Use Disorder (OUD)
  • 3:00 PM – 3:10 PM
    Live Q&A Panel
  • 3:10 PM – 3:25 PM
    Break
  • 3:25 PM – 4:00 PM
    Chairs Roundtable: Cancer Care Disparities
  • 4:00 PM – 4:10 PM
    Live Q&A Panel
  • Thursday, April 28, 2022
  • 9:00 AM – 9:10 AM
    Welcome
  • 9:10 AM – 9:45 AM
    Should Cancer Patients Get the COVID-19 Vaccine?
  • 9:45 AM – 9:55 AM
    Live Q&A Panel
  • 9:55 AM – 10:10 AM
    Break
  • 10:10 AM – 10:45 AM
    Essential Pharmacy Strategies for Antibody-Drug Conjugate Therapy in Hematologic Malignancies: What, When, Why, and How?
  • 10:45 AM – 10:55 AM
    Live Q&A Panel
  • 10:55 AM – 11:10 AM
    Break
  • 11:10 AM – 11:45 AM
    Challenging Case Review – Myeloma & Lymphoma
  • 11:45 AM – 11:55 AM
    Live Q&A Panel
  • 11:55 AM – 12:10 PM
    Break
  • 12:10 PM – 12:55 PM
    Stem Cell Transplant: Focus on Chronic Graft vs Host Disease
  • 12:55 PM – 1:10 PM
    Break
  • 1:10 PM – 2:10 PM
    Non-CME Innovation Theater
  • 2:10 PM – 2:25 PM
    Break
  • 2:25 PM – 3:00 PM
    Advances in the Treatment of Bladder Cancer
  • 3:00 PM – 3:10 PM
    Live Q&A Panel
  • 3:10 PM – 3:25 PM
    Break
  • 3:25 PM – 4:00 PM
    The Burden of Cure
  • 4:00 PM – 4:10 PM
    Live Q&A Panel
  • Friday, April 29, 2022
  • 9:00 AM – 9:10 AM
    Welcome
  • 9:10 AM – 9:45 AM
    Glioblastoma: Review of Failures and Future Directions
  • 9:45 AM – 9:55 AM
    Live Q&A Panel
  • 9:55 AM – 10:10 AM
    Break
  • 10:10 AM – 10:55 AM
    Breast Cancer: An Overview and Current Treatment Strategies
  • 10:55 AM – 11:10 AM
    Break
  • 11:10 AM – 11:40 AM
    Networking with the Faculty
  • 11:40 AM – 11:55 AM
    Break
  • 11:55 AM – 12:30 PM
    Challenging Case Review - Care of the Individual with Renal Cell Carcinoma (RCC)
  • 12:30 PM – 12:40 PM
    Live Q&A Panel
  • 12:40 PM – 12:55 PM
    Break
  • 12:55 PM – 1:40 PM
    Neuroendocrine Tumors
  • 1:40 PM – 1:55 PM
    Break
  • 1:55 PM – 2:30 PM
    Challenging Cases and Debate Over Ret Mutated Thyroid Cancer
  • 2:30 PM – 2:40 PM
    Live Q&A Panel
  • 2:40 PM – 2:55 PM
    Break
  • 2:55 PM – 3:40 PM
    Pediatric Cancer: New Data on Asparaginase Products
  • 3:40 PM – 3:55 PM
    Closing Remarks
  • Friday, August 12, 2022
  • 10:10 AM – 10:55 AM
    Updates on Cervical Cancer
  • Wednesday, November 16, 2022
  • 9:00 AM – 9:10 AM
    Welcome and Introduction
  • 9:10 AM – 9:45 AM
    Should We Transplant Patients with Multiple Myeloma (MM)
  • 9:45 AM – 9:55 AM
    Live Q&A Panel
  • 9:55 AM – 10:10 AM
    Exhibit Hall
  • 10:10 AM – 10:45 AM
    Bispecific Antibody Therapy (BsAbs): A New Path Forward in the Treatment of R/R Multiple Myeloma
  • 10:45 AM – 10:55 AM
    Live Q&A Panel
  • 11:10 AM – 11:45 AM
    Challenging Case Review – Breast Cancer Patients
  • 11:45 AM – 11:55 AM
    Live Q&A Panel
  • 11:55 AM – 12:10 PM
    Exhibit Hall
  • 12:10 PM – 12:55 PM
    Stem Cell Transplant: Focus on Chronic Graft vs Host Disease
  • 12:55 PM – 1:10 PM
    Exhibit Hall
  • 1:10 PM – 1:45 PM
    Essential Pharmacy Strategies for Antibody-Drug Conjugate Therapy in Hematologic Malignancies: What, When, Why, and How?
  • 1:45 PM – 1:55 PM
    Live Q&A Panel
  • 1:55 PM – 2:10 PM
    Exhibit Hall
  • 2:10 PM – 2:45 PM
    Pain Management in Cancer Patients with Opioid Use Disorder (OUD)
  • 2:45 PM – 2:55 PM
    Live Q&A Panel
  • 2:55 PM – 3:10 PM
    Exhibit Hall
  • 3:10 PM – 3:45 PM
    Chairs Roundtable: Cancer Care Disparities
  • 3:45 PM – 3:55 PM
    Live Q&A Panel
  • Thursday, November 17, 2022
  • 9:00 AM – 9:10 AM
    Welcome
  • 9:10 AM – 9:45 AM
    Should Cancer Patients Get the COVID-19 Vaccine?
  • 9:45 AM – 9:55 AM
    Live Q&A Panel
  • 9:55 AM – 10:10 AM
    Exhibit Hall
  • 10:10 AM – 10:45 AM
    Next generation ALK/ROS1/NTRK-Targeted Agents for NSCLC: Adverse Event Management and Patient Considerations for the Oncology Pharmacist
  • 10:45 AM – 10:55 AM
    Live Q&A Panel
  • 10:55 AM – 11:10 AM
    Exhibit Hall
  • 11:10 AM – 11:45 AM
    Care of the Individual with Renal Cell Carcinoma (RCC)
  • 11:45 AM – 11:55 AM
    Live Q&A Panel
  • 11:55 AM – 0:10 AM
    Exhibit Hall
  • 12:10 PM – 12:55 PM
    Breast Cancer: An Overview and Current Treatment Strategies
  • 12:55 PM – 1:10 PM
    Exhibit Hall
  • 1:10 PM – 1:55 PM
    Neuroendocrine Tumors
  • 1:55 PM – 2:10 PM
    Exhibit Hall
  • 2:10 PM – 2:45 PM
    Advances in the Treatment of Bladder Cancer
  • 2:45 PM – 2:55 PM
    Live Q&A Panel
  • 2:55 PM – 3:10 PM
    Exhibit Hall
  • 3:10 PM – 3:45 PM
    The Burden of Cure
  • 3:45 PM – 3:55 PM
    Live Q&A Panel
  • Friday, November 18, 2022
  • 9:00 AM – 9:10 AM
    Welcome
  • 9:10 AM – 9:45 AM
    Glioblastoma: Review of Failures and Future Directions
  • 9:45 AM – 9:55 AM
    Live Q&A Panel
  • 9:55 AM – 10:10 AM
    Exhibit Hall
  • 10:10 AM – 10:55 AM
    Updates on Cervical Cancer
  • 10:55 AM – 11:10 AM
    Exhibit Hall
  • 11:10 AM – 11:45 AM
    Challenging Case Review – Myeloma & Lymphoma
  • 11:45 AM – 11:55 AM
    Live Q&A Panel
  • 11:55 AM – 12:10 PM
    Exhibit Hall
  • 12:10 PM – 12:55 PM
    Updates in Prostate Cancer: Treatment Intensification and Lutetium-Prostate Specific Membrane Antigen PSMA Directed Therapy
  • 12:55 PM – 1:10 PM
    Exhibit Hall
  • 1:10 PM – 1:45 PM
    Challenging cases and debate over ret mutated thyroid cancer
  • 1:45 PM – 1:55 PM
    Live Q&A Panel
  • 1:55 PM – 2:10 PM
    Exhibit Hall
  • 2:10 PM – 2:55 PM
    Pediatric Cancer: New Data on Asparaginase Products
  • 2:55 PM – 3:05 PM
    Closing Remarks
  • Exclusive Content
  • 45 minutes
    Current and Emerging Treatments for Advanced Cutaneous Melanoma
  • 45 minutes
    Gastroesophageal Cancers and Immunotherapy Updates
  • 45 minutes
    Inpatient and Outpatient Treatment Algorithms for the Management of Acute Myeloid Lymphoma in Patients with Genetic Mutations
  • 45 minutes
    NON-CME ACCREDITED SESSION: Varying Perspectives on Coverage Designs and Regulatory Rules That Create Challenges to Drug Access
  • 45 minutes
    Optimizing Patient Outcomes in Chronic Myeloid Leukemia
  • 45 minutes
    Prophylactic Antifungals in Oncology Populations
  • 45 minutes
    Updates in Prostate Cancer: Treatment Intensification and Lutetium-Prostate Specific Membrane Antigen PSMA Directed Therapy
  • 45 minutes
    Updates on Cervical Cancer